We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$550M
AUM Growth
+$69.7M
Cap. Flow
+$1.12M
Cap. Flow %
0.2%
Top 10 Hldgs %
19.3%
Holding
562
New
46
Increased
72
Reduced
103
Closed
24

Top Buys

Rank Stock Value
1
S
Sprint Corporation
S
+$2.48M
2
CELG
Celgene Corp
CELG
+$1.05M
3
ABT icon
Abbott
ABT
+$1.04M
4
CVS icon
CVS Health
CVS
+$741K
5
AGN
Allergan plc
AGN
+$725K

Top Sells

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$1.97M
2
PFE icon
Pfizer
PFE
+$1.6M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$1.16M
4
MRK icon
Merck
MRK
+$1.02M
5
ZTS icon
Zoetis
ZTS
+$999K

Sector Composition

Rank Sector Weight
1 Technology 19.73%
2 Financials 15.47%
3 Industrials 12.95%
4 Healthcare 12.28%
5 Consumer Discretionary 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LITE icon
201
Lumentum
LITE
$55.5B
$592K 0.11%
10,475
-3,000
-22% -$144K
ACHC icon
202
Acadia Healthcare
ACHC
$2.76B
$586K 0.11%
20,000
– –
MCK icon
203
McKesson
MCK
$100B
$585K 0.11%
5,000
-3,000
-38% -$370K
HPQ icon
204
HP
HPQ
$24.9B
$583K 0.11%
30,000
– –
ECHO
205
EchoStar
ECHO
$24.4B
$583K 0.11%
19,744
– –
NAV
206
DELISTED
Navistar International
NAV
$581K 0.11%
18,000
-3,000
-14% -$99.7K
LPSN icon
207
LivePerson
LPSN
$21.8M
$580K 0.11%
1,333
– –
PACB icon
208
Pacific Biosciences
PACB
$435M
$578K 0.11%
80,000
+30,000
+60% +$217K
ELV icon
209
Elevance Health
ELV
$81.5B
$574K 0.1%
+2,000
New +$578K
EW icon
210
Edwards Lifesciences
EW
$49.6B
$574K 0.1%
+9,000
New +$514K
PYX
211
DELISTED
Pyxus International, Inc.
PYX
$573K 0.1%
24,000
-3,000
-11% -$62.6K
CHGG icon
212
Chegg
CHGG
$110M
$572K 0.1%
15,000
-3,000
-17% -$109K
KOP icon
213
Koppers
KOP
$943M
$572K 0.1%
22,000
-14,000
-39% -$329K
AMGN icon
214
Amgen
AMGN
$208B
$570K 0.1%
+3,000
New +$573K
SNX icon
215
TD Synnex
SNX
$20.4B
$567K 0.1%
11,894
– –
ISCA
216
DELISTED
International Speedway Corp
ISCA
$567K 0.1%
13,000
+3,000
+30% +$131K
JBTM
217
JBT Marel
JBTM
$7.21B
$566K 0.1%
6,160
-3,000
-33% -$253K
ACAD icon
218
Acadia Pharmaceuticals
ACAD
$4.43B
$564K 0.1%
21,000
– –
WW
219
DELISTED
WW International
WW
$564K 0.1%
28,000
+17,000
+155% +$470K
A icon
220
Agilent Technologies
A
$39.1B
$563K 0.1%
+7,000
New +$531K
BFYT
221
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$563K 0.1%
21,000
+1,000
+5% +$35.4K
NTCT icon
222
NETSCOUT
NTCT
$2.96B
$561K 0.1%
19,977
– –
ACM icon
223
Aecom
ACM
$9.3B
$560K 0.1%
18,879
– –
CADE
224
DELISTED
Cadence Bancorporation
CADE
$557K 0.1%
30,000
+6,000
+25% +$114K
GFF icon
225
Griffon
GFF
$3.95B
$554K 0.1%
30,000
– –
7 8
9
10 11

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q1 2019 Portfolio in Review

As of Q1 2019, NJ State Employees Deferred Compensation Plan held 562 positions worth $550M, up 15% from $480M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q1 2019 filing shows 46 new, 72 increased, 103 reduced and 24 closed positions. Its largest new stake was Allergan plc: 5,000 shares worth $732K. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $1.97M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • NJ State Employees Deferred Compensation Plan's largest Q1 2019 buy was Allergan plc: 5,000 shares worth $732K.
  • NJ State Employees Deferred Compensation Plan added most to Sprint Corporation in Q1 2019, an estimated $2.48M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q1 2019 reduction was Pfizer, cutting an estimated $1.6M.
  • NJ State Employees Deferred Compensation Plan fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $1.97M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 19% of its $550M portfolio in Q1 2019.
  • NJ State Employees Deferred Compensation Plan opened 46 new positions and closed 24 in Q1 2019.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 15% quarter-over-quarter to $550M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2019, filed 1 May 2019.